NYKD — Nykode Therapeutics ASA Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapSucker Stock

Annual balance sheet for Nykode Therapeutics ASA, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	R2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	31.6	208	228	206	162
Net Total Accounts Receivable
Net Total Receivables	1.26	20.1	26.2	4.33	1.07
Prepaid Expenses
Total Other Current Assets
Total Current Assets	33.2	229	256	212	166
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.173	0.408	9.16	9.53	10.5
Net Intangible Assets
Long Term Notes Receivable
Other Long Term Assets
Total Assets	33.4	230	266	221	208
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	4.32	13.2	31.4	39	20.6
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	5.75	51.2	71.5	64.5	36.9
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	27.6	179	194	157	171
Total Liabilities & Shareholders' Equity	33.4	230	266	221	208
Total Common Shares Outstanding